Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EMTensor is a private medical device company developing portable electromagnetic tomography brain imaging systems for rapid stroke assessment and monitoring. Its lead product, the EMTensor BrainScanner, is designed to complement CT and MRI by providing non-ionizing, bedside or in-ambulance brain imaging for triage and continuous monitoring. The company positions its technology as compact, low-cost, and suitable for emergency rooms, intensive care units, ambulances, and other point-of-care settings. EMTensor was founded in 2012 in Vienna by Professor Serguei Semenov and angel investors, and it reports support from public agencies in the U.S., Switzerland, and Austria. The company states that its products remain under clinical investigation and are not yet available for sale.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EMTensor.